Nanobiotix is trading at $45.21, up 7.51%, with no confirmed catalyst identified.

  • Nanobiotix gained 9.76% during the August 17 regular session before extending higher after hours.
  • No clearly dated August 17 company announcement, earnings release, regulatory decision, or analyst action was identified; available coverage highlights earlier clinical data and analyst valuation changes.
  • The broader market was lower, so market-wide momentum does not clearly explain the move; monitor for delayed company news.